Consistent with our previous results and the intrinsically low AR frequency in the other CLL cell lines, ZCL278 treatment did not significantly modify apoptosis in these cell lines (Figure 3C and Supplementary Figure S3C). Here, AR is linked to B-cell chronic lymphocytic leukemia.